🇺🇸 Anthracyclines in United States
63 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 28 March 2025 – 28 March 2026
- Total reports: 63
Most-reported reactions
- Cardiac Failure — 11 reports (17.46%)
- Malignant Neoplasm Progression — 11 reports (17.46%)
- Drug Ineffective — 7 reports (11.11%)
- Acute Graft Versus Host Disease — 6 reports (9.52%)
- Acute Myeloid Leukaemia — 6 reports (9.52%)
- Disease Progression — 6 reports (9.52%)
- Breast Cancer — 4 reports (6.35%)
- Cardiomyopathy — 4 reports (6.35%)
- Death — 4 reports (6.35%)
- Multi-Organ Failure — 4 reports (6.35%)
Other Other approved in United States
Frequently asked questions
Is Anthracyclines approved in United States?
Anthracyclines does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Anthracyclines in United States?
University Hospital Muenster is the originator. The local marketing authorisation holder may differ — check the official source linked above.